Cargando…
Genetic Subtype-Phenotype Analysis of Growth Hormone Treatment on Psychiatric Behavior in Prader-Willi Syndrome
Prader-Willi syndrome (PWS) is a complex multisystemic condition caused by a lack of paternal expression of imprinted genes from the 15q11.2–q13 region. Limited literature exists on the association between molecular classes, growth hormone use, and the prevalence of psychiatric phenotypes in PWS. In...
Autores principales: | Montes, Andrea S., Osann, Kathryn E., Gold, June Anne, Tamura, Roy N., Driscoll, Daniel J., Butler, Merlin G., Kimonis, Virginia E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690822/ https://www.ncbi.nlm.nih.gov/pubmed/33114160 http://dx.doi.org/10.3390/genes11111250 |
Ejemplares similares
-
Molecular Classes and Growth Hormone Treatment Effects on Behavior and Emotion in Patients with Prader–Willi Syndrome
por: Mahmoud, Ranim, et al.
Publicado: (2022) -
Early Diagnosis in Prader–Willi Syndrome Reduces Obesity and Associated Co-Morbidities
por: Kimonis, Virginia E., et al.
Publicado: (2019) -
Frequency of Births Due to Assisted Reproductive Technology (ART) in Prader-Willi Syndrome
por: Gold, June-Anne, et al.
Publicado: (2013) -
Clinical Trials in Prader–Willi Syndrome: A Review
por: Mahmoud, Ranim, et al.
Publicado: (2023) -
A randomized pilot efficacy and safety trial of diazoxide choline controlled-release in patients with Prader-Willi syndrome
por: Kimonis, Virginia, et al.
Publicado: (2019)